Literature DB >> 31690843

Clinical decision-making with AR-V7.

Clemens Thoma1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31690843     DOI： 10.1038/s41585-019-0259-2

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer.

Authors:  Ryon P Graf; Melanie Hullings; Ethan S Barnett; Emily Carbone; Ryan Dittamore; Howard I Scher
Journal:  Eur Urol       Date:  2019-10-21       Impact factor: 20.096
  1 in total
  2 in total

Review 1.  Research Progress for the Clinical Application of Circulating Tumor Cells in Prostate Cancer Diagnosis and Treatment.

Authors:  Mei Yang; Xiaotian Zhang; Lixia Guo; Xiumin Liu; Jing Wu; Hongquan Zhu
Journal:  Biomed Res Int       Date:  2021-01-08       Impact factor: 3.411

2.  The differential presence of human polyomaviruses, JCPyV and BKPyV, in prostate cancer and benign prostate hypertrophy tissues.

Authors:  Chenghuang Shen; Chunliang Tung; Chunnun Chao; Yeongchin Jou; Shupei Huang; Menghsiao Meng; Deching Chang; Peilain Chen
Journal:  BMC Cancer       Date:  2021-10-24       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.